HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Clodia Osipo Selected Research
Clodia Osipo Research Topics
Disease
28
Breast Neoplasms (Breast Cancer)
06/2022 - 11/2003
27
Neoplasms (Cancer)
06/2022 - 11/2003
3
Osteoporosis
04/2006 - 11/2003
2
Tics (Tic)
01/2020 - 10/2019
1
Genomic Instability
10/2017
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1
Triple Negative Breast Neoplasms
06/2011
1
Neoplasm Metastasis (Metastasis)
06/2010
1
Lobular Carcinoma
07/2008
1
Hypersensitivity (Allergy)
04/2006
1
Endometrial Neoplasms (Endometrial Cancer)
09/2005
Drug/Important Bio-Agent (IBA)
12
Proteins (Proteins, Gene)
FDA Link
01/2020 - 11/2003
9
Estrogen Receptors
IBA
01/2020 - 02/2005
9
Tamoxifen
FDA Link
Generic
07/2008 - 11/2003
7
Trastuzumab (Herceptin)
FDA Link
01/2018 - 09/2005
7
Fulvestrant (Faslodex)
FDA Link
02/2007 - 11/2003
7
Estrogens (Estrogen)
FDA Link
02/2007 - 11/2003
6
Estradiol (Delestrogen)
FDA Link
Generic
10/2019 - 11/2003
6
Estrogen Receptor alpha
IBA
07/2008 - 11/2003
5
Messenger RNA (mRNA)
IBA
01/2018 - 11/2003
5
Phosphotransferases (Kinase)
IBA
10/2017 - 09/2005
4
Amyloid Precursor Protein Secretases (beta-Secretase)
IBA
01/2020 - 07/2008
4
ErbB Receptors (EGF Receptor)
IBA
06/2016 - 04/2006
4
Biomarkers (Surrogate Marker)
IBA
04/2013 - 07/2008
4
Estrogen Receptor Modulators (Antiestrogen)
IBA
07/2008 - 09/2004
4
Raloxifene Hydrochloride (Evista)
FDA Link
04/2006 - 11/2003
3
Lapatinib (GW572016)
FDA Link
01/2018 - 08/2015
3
Jagged-1 Protein
IBA
01/2018 - 07/2008
3
Notch Receptors
IBA
01/2014 - 07/2008
3
Epidermal Growth Factor (EGF)
IBA
01/2013 - 12/2009
3
Selective Estrogen Receptor Modulators (SERM)
IBA
04/2006 - 11/2003
3
Aromatase Inhibitors
IBA
12/2005 - 09/2004
2
Phytoestrogens (Phytoestrogen)
IBA
06/2022 - 01/2020
2
human ERBB2 protein
IBA
01/2020 - 08/2015
2
Progesterone Receptors (Progesterone Receptor)
IBA
01/2020 - 01/2012
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2018 - 01/2014
2
Tyrosine (L-Tyrosine)
FDA Link
10/2017 - 02/2007
2
NF-kappa B (NF-kB)
IBA
01/2008 - 11/2003
2
Glycogen Synthase (Synthase I)
IBA
02/2007 - 04/2006
2
Insulin-Like Growth Factor I (IGF-1)
IBA
02/2007 - 09/2005
2
Gefitinib (Iressa)
FDA Link
11/2006 - 04/2006
1
naringenin
IBA
01/2020
1
Resveratrol
IBA
01/2020
1
Quercetin
IBA
01/2020
1
Genistein
IBA
01/2020
1
Apigenin
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
10/2019
1
Excipients (Suspending Agents)
IBA
10/2019
1
Potassium Channels (Potassium Channel)
IBA
01/2018
1
Potassium
IBA
01/2018
1
1,3- bis(2- hydroxy- 5- trifluoromethylphenyl)urea
IBA
01/2018
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2018
1
Ion Channels (Ion Channel)
IBA
01/2018
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018
1
BRCA1 Protein
IBA
10/2017
1
Mechanistic Target of Rapamycin Complex 1
IBA
01/2017
1
Deubiquitinating Enzymes
IBA
01/2017
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
01/2016
1
Mitogen-Activated Protein Kinase Kinase Kinase 11
IBA
08/2015
1
Mitogen-Activated Protein Kinases
IBA
01/2014
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2014
1
Tumor Biomarkers (Tumor Markers)
IBA
04/2013
1
Ligands
IBA
01/2013
1
Hormones (Hormone)
IBA
01/2013
1
Formaldehyde (Formol)
FDA Link
01/2012
1
Proto-Oncogene Proteins c-ets
IBA
06/2011
1
Small Interfering RNA (siRNA)
IBA
06/2011
1
MRK 003
IBA
06/2011
1
Notch4 Receptor
IBA
06/2011
1
tyrosine receptor (receptor, tyrosine)
IBA
12/2009
1
Gamma Secretase Inhibitors and Modulators
IBA
01/2009
1
Cathepsin D
IBA
02/2007
1
pertuzumab
IBA
02/2007
1
Growth Factor Receptors
IBA
04/2006
1
Nuclear Receptor Coactivator 3
IBA
04/2006
1
Cyclin D1
IBA
04/2006
1
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
04/2006
1
Caspase 7
IBA
04/2006
1
Angiogenesis Inhibitors
IBA
12/2005
1
Aromatase (CYP19)
IBA
12/2005
1
Insulin-Like Peptides
IBA
09/2005
1
Insulin Receptor Substrate Proteins
IBA
09/2005
1
Growth Inhibitors
IBA
09/2005
1
Anastrozole (Arimidex)
FDA Link
Generic
02/2005
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
09/2004
1
Fas Ligand Protein (Fas Ligand)
IBA
11/2003
1
Death Domain Receptors
IBA
11/2003
Therapy/Procedure
19
Therapeutics
06/2022 - 09/2004
3
Drug Therapy (Chemotherapy)
01/2020 - 09/2004
1
Hormone Replacement Therapy (Therapy, Hormone Replacement)
06/2022
1
Radiotherapy
01/2018
1
Molecular Targeted Therapy
01/2014
1
Transplantation
02/2005